Diabetic nephropathy (DN), a leading cause of end-stage renal disease (ESRD) affecting∼
20–30% diabetics, is associated with increased cardiovascular mortality. The progression of …

Diabetic nephropathy (DN) is the leading cause of end-stage renal disease (ESRD)
worldwide. Its pathogenesis encompasses functional alterations involving elevated …

Diabetic nephropathy is the leading cause of end-stage renal disease in the United States.
The progression of kidney disease in patients with diabetes can take many years, and …

Diabetic nephropathy (DN) is a major cause of end-stage renal disease and affects a large
number of individuals with diabetes. However, the development of specific treatments for DN …

Diabetic nephropathy affects 30–40% of people with diabetes, and is the leading cause of
end‐stage kidney disease. The current treatment paradigm relies on early detection …

The burden of diabetes mellitus is relentlessly increasing. Diabetic nephropathy is the most
common cause of end-stage renal disease (ESRD) worldwide and a major cause of …

The kidney is arguably the most important target of microvascular damage in diabetes. A
substantial proportion of individuals with diabetes will develop kidney disease owing to their …

The consensus management of diabetic nephropathy (DN) in 2015 involves good control of
glycaemia, dyslipidaemia and blood pressure (BP). Blockade of the renin–angiotensin …

Background: Diabetic nephropathy (DN) often results in end-stage renal disease, and this is
the most common reason for initiation of dialysis in the United States. Complications of …

Approximately 20 to 40% of patients with type 1 or type 2 diabetes develop diabetic kidney
disease. It is a clinical syndrome characterized by persistent albuminuria (> 300 mg/24 h, or …